Living with idiopathic short stature (ISS) may entail significant risks to psychological functioning and quality of life. Apparent inconsistency among study findings can be resolved if methodological differences among study designs are taken into account (i.e., definition of particular endpoints, sample selection from clinic or population, source of report, specific or generic assessment instruments, statistical control of confounders). Some individuals fail and others succeed in mastering the challenges of ISS. The principles of multifinality and equifinality may explain the emergence of a broad variation of individuals with ISS as a result of an interaction of the individual medical and auxological features on the one side, and psychosocial risk and protective factors on the other. As a result, patients may show heterogeneous developmental outcomes ranging from clinical psychopathology to development of resilience. A taxonomy of four distinct pathways of adaptation to ISS is delineated as a basis for case formulation and treatment planning. Psychological intervention in ISS includes counseling, cognitive-behavioral therapy and assertiveness training to improve psychological functioning via enhancement of target coping behaviors for critical situations.

Journal Section:
Paper
Keywords:
Idiopathic short stature, Growth hormone therapy, Quality of life, Coping, Adaptation
1.
Brütt AL, Sandberg DE, Chaplin J, Wollmann H, Noeker M, Kołtowska-Häggström M, Bullinger M: Assessment of health-related quality of life and patient satisfaction in children and adolescents with growth hormone deficiency or idiopathic short stature – part 1: a critical evaluation of available tools. Horm Res 2009;72:65–73.
[PubMed]
2.
Bullinger M, Kołtowska-Häggström M, Sandberg D, Chaplin J, Wollmann H, Noeker M, Brütt AL: Health-related quality of life of children and adolescents with growth hormone deficiency or idiopathic short stature – part 2: available results and future directions. Horm Res 2009;72:74–81.
[PubMed]
https://doi.org/10.1159%2F000232159
3.
Downie AB, Mulligan J, Stratford RJ, Betts PR, Voss LD: Are short normal children at a disadvantage? The Wessex growth study. BMJ 1997;314:97–100.
[PubMed]
4.
Haverkamp F, Noeker M: ‘Short stature in children – a questionnaire for parents’: a new instrument for growth disorder-specific psychosocial adaptation in children. Qual Life Res 1998;7:447–455.
[PubMed]
https://doi.org/10.1023%2FA%3A1008862021532
5.
Kranzler JH, Rosenbloom AL, Proctor B, Diamond FB Jr, Watson M: Is short stature a handicap? A comparison of the psychosocial functioning of referred and nonreferred children with normal short stature and children with normal stature. J Pediatr 2000;136:96–102.
[PubMed]
https://doi.org/10.1016%2FS0022-3476%2800%2990057-X
6.
Noeker M, Haverkamp F: Adjustment in conditions with short stature: a conceptual framework. J Pediatr Endocrinol Metab 2000;13:1585–1594.
[PubMed]
https://doi.org/10.1515%2FJPEM.2000.13.9.1585
7.
Noeker M: Management of idiopathic short stature: psychological endpoints, assessment strategies and cognitive-behavioral intervention. Horm Res 2009;71(suppl 1):75–81.
[PubMed]
https://doi.org/10.1159%2F000178044
8.
Sandberg DE, Bukowski WM, Fung CM, Noll RB: Height and social adjustment: are extremes a cause for concern and action? Pediatrics 2004;114:744–750.
[PubMed]
https://doi.org/10.1542%2Fpeds.2003-1169-L
9.
Voss LD, Mulligan J: Bullying in school: are short pupils at risk? Questionnaire study in a cohort. BMJ 2000;320:612–613.
[PubMed]
https://doi.org/10.1136%2Fbmj.320.7235.612
© 2011 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2011
You do not currently have access to this content.